Fertility and Sterility

Fertility evaluation of infertile women: a committee opinion.  116:1255-1265. 2021

Obesity and reproduction: a committee opinion.  116:1266-1285. 2021

One size does not fit all: variations by ethnicity in demographic characteristics of men seeking fertility treatment across North America.  116:1287-1294. 2021

Systemic chronic subclinical inflammation, adipose tissue dysfunction, and polycystic ovary syndrome: three major forces intertwined.  116:1147-1148. 2021

Adiposity in polycystic ovary syndrome: excess versus dysfunction.  116:87-88. 2021

Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.  115:1557-1568. 2021

Financial fluency: demystifying accounting and business planning for the reproductive medicine specialist.  115:7-16. 2021

Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion.  114:1158-1164. 2020

Testing and interpreting measures of ovarian reserve: a committee opinion.  114:1151-1157. 2020

INVESTIGATION OF THE RACIAL DISPARITIES AMONGST SEMEN ANALYSES IN WHITE, BLACK, HISPANIC, AND ASIAN MEN.  114:e242-e243. 2020

OVARIAN AGING AND REPRODUCTIVE SENESCENCE IN MOUSE MODEL OF MITOCHONDRIAL DYSFUNCTION.  114:e74. 2020

TO TREAT OR NOT TO TREAT: PERCEPTIONS OF THE INITIAL AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE COVID-19 RECOMMENDATIONS AMONG WOMEN'S HEALTH PROVIDERS.  114:e175. 2020

Evidence-based treatments for couples with unexplained infertility: a guideline.  113:305-322. 2020

Interpretation of clinical trial results: a committee opinion.  113:295-304. 2020

Reproductive endocrinologists are the gatekeepers for male infertility care in North America: results of a North American survey on the referral patterns and characteristics of men presenting to male infertility specialists for infertility investigations.  112:657-662. 2019

Postoperative adhesions in gynecologic surgery: a committee opinion.  112:458-463. 2019

Defining what is normal: the key to the diagnosis of polycystic ovary syndrome (and any other disorder for that matter…).  111:681-682. 2019

Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion.  111:659-663. 2019

Is antimüllerian hormone an early marker or an in utero effector of incipient polycystic ovary syndrome?.  111:264-265. 2019

Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.  111:389-396. 2019

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.  110:364-379. 2018

Does the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age?.  108:959-960. 2017

Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.  106:1510-1520.e2. 2016

Criteria, prevalence, and phenotypes of polycystic ovary syndrome.  106:6-15. 2016

Evolutionary determinants of polycystic ovary syndrome: part 2.  106:42-47. 2016

Introduction: Determinants of polycystic ovary syndrome.  106:4-5. 2016

Evidence-based approach to unexplained infertility: a systematic review.  105:1566-1574.e1. 2016

Association study of androgen signaling pathway genes in polycystic ovary syndrome.  105:467-473.e4. 2016

How do patient perceived determinants influence the decision-making process to accept or decline preimplantation genetic screening?.  105:188-193. 2016

Berberine inhibits the proliferation of human uterine leiomyoma cells.  103:1098-1106. 2015

Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes.  104:1522-1526. 2015

Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.  101:227-231. 2014

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.  101. 2014

Impact of body mass index on the correlation of follicle stimulating hormone and antral follicle count with anti-mullerian hormone to measure ovarian reserve.  100:s160-s161. 2013

Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome.  99:599-604. 2013

Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive.  100. 2013

Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)..  98:948-56.e1. 2012

Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome.  96:1043-1047. 2011

Reply of the authors.  96. 2011

Defining hirsutism in Chinese women: A cross-sectional study.  96:792-796. 2011

Defining case-control studies.  95. 2011

Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome.  95. 2011

National semen analysis reference range reporting: Adherence to the 1999 World Health Organization guidelines 10 years later.  95:2320-2323. 2011

Polycystic ovary syndrome: An ancient disorder?.  95:1544-1548. 2011

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: A systematic review and meta-analysis.  95. 2011

Reanalyzing the modified Ferriman-Gallwey score: Is there a simpler method for assessing the extent of hirsutism?.  96. 2011

Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.  95. 2011

Association of cystic fibrosis genetic modifiers with congenital bilateral absence of the vas deferens.  94:2122-2127. 2010

Self-assessed knowledge of treatment and fertility preservation in young women with breast cancer.  94:2396-2398. 2010

Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.  94:690-693. 2010

The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.  94:684-689. 2010

Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria.  93:1938-1941. 2010

An investigation of the visual disturbances experienced by patients on clomiphene citrate.  93:1169-1172. 2010

Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation.  94. 2010

Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.  94. 2010

Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS.  92:643-647. 2009

Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-h295r adrenocortical cell line.  92:793-797. 2009

Fifteen-year trend in the use of reproductive surgery in women in the United States.  92:727-735. 2009

Reply of the Authors: Criteria for the polycystic ovary syndrome.  92. 2009

Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells.  91:2551-2556. 2009

Reply of the Authors: Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.  91. 2009

Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.  91:1848-1852. 2009

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.  91:456-488. 2009

Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3.  90:2291-2297. 2008

Racial differences in self-reported infertility and risk factors for infertility in a cohort of black and white women: The CARDIA Women's Study.  90:1640-1648. 2008

Effect of oral estrogen on substrate utilization in postmenopausal women.  90:1275-1278. 2008

Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women.  88:1609-1617. 2007

Repeat vasectomy reversal yields high success rates.  88:217-219. 2007

Reply of the Authors.  88:249-250. 2007

Effect of female partner age on pregnancy rates after vasectomy reversal.  87:1340-1344. 2007

Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome.  87:1473-1476. 2007

Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.  87:862-869. 2007

Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.  86:1688-1693. 2006

Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate.  86:1664-1668. 2006

Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005.  86:1318-1320. 2006

Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.  86:411-417. 2006

Reproducibility of the adrenal androgen response to adrenocorticotropic hormone stimulation.  86:484-486. 2006

Ovarian expression of markers associated with proliferation or apoptosis in women with diminished ovarian reserve.  86:176-185. 2006

Family size in women with polycystic ovary syndrome.  85:1837-1839. 2006

Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.  85:1425-1431. 2006

Role of diet in the treatment of polycystic ovary syndrome.  85:679-688. 2006

Reply of the Author [2].  85:530. 2006

Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.  86:S7. 2006

Polycystic ovary syndrome in Mexican-Americans: Prevalence and association with the severity of insulin resistance.  84:766-769. 2005

Phenotypic spectrum of polycystic ovary syndrome: Clinical and biochemical characterization of the three major clinical subgroups.  83:1717-1723. 2005

Diagnostic criteria for polycystic ovary syndrome: A reappraisal.  83:1343-1346. 2005

Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess.  83:371-375. 2005

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.  83:1454-1460. 2005

Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.  82:973-975. 2004

Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.  81:126-131. 2004

Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.  81:120-125. 2004

Potential cofounders in the laparoscopic detection of endometriosis [12] (multiple letters).  81:1722-1723. 2004

Androgen excess is the key element in polycystic ovary syndrome.  80:252-254. 2003

We should avoid the indiscriminate use of insulin sensitizers in women with polycystic ovary syndrome.  80:264-265. 2003

Visualization of the epigastric vessels and bladder before laparoscopic trocar placement.  80:209-212. 2003

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.  79:932-937. 2003

Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate.  80:1450-1453. 2003

Role of reproductive surgeons and the Society of Reproductive Surgeons.  78:916-917. 2002

Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome.  77:1125-1127. 2002

Adrenal progestogen and androgen production in 21-hydroxylase-deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulation.  77:750-753. 2002

Should employer-sponsored health insurance benefits be made public?.  77:216-217. 2002

Fertility outcomes after electroejaculation in men with spinal cord injury [3].  78:429-431. 2002

Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.  77:1095-1105. 2002

Electroejaculation and assisted reproductive technologies in the treatment of anejaculatory infertility.  76:1249-1255. 2001

Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: Preliminary studies.  76:730-735. 2001

Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormones.  76:823-825. 2001

Hyperandrogenemia in patients presenting with acne.  75:889-892. 2001

A one-year experience with a capitated health care plan for infertility.  75:749-753. 2001

Low seminal plasma folate concentrations are associated with low sperm density and count in male smokers and nonsmokers.  75:252-259. 2001

Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.  75:53-58. 2001

Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome.  75:625-628. 2001

A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome.  74:1237-1240. 2000

Examination of the chin or lower abdomen only for the prediction of hirsutism.  74:980-983. 2000

The time has come to simplify the evaluation of the hirsute patient.  74:870-872. 2000

Adrenocortical hyperresponsivity to adrenocorticotropic hormone: A mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia.  74:329-334. 2000

Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico.  74:59-62. 2000

Reproductive medicine and research: Contract laboratories vs. the university-based researcher.  73:677-679. 2000

11β-Hydroxyandrostenedione and δ⁵-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.  72:996-1000. 1999

Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: A prospective study.  72:915-925. 1999

Adrenal androgen excess in hyperandrogenism: Relation to age and body mass.  71:671-674. 1999

Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome.  71:436-438. 1999

Effect of seminal oxidative stress on fertility after vasectomy reversal.  71:249-255. 1999

Preimplantation genetic diagnosis of Marfan syndrome with the use of fluorescent polymerase chain reaction and the automated laser fluorescence DNA sequencer.  71:163-166. 1999

Sperm retrieval and intracytoplasmic sperm injection in patients with prune-belly syndrome [2].  72:948-949. 1999

Idiopathic hirsutism: An uncommon cause of hirsutism in Alabama.  70:274-278. 1998

Comparison of low-technology and high-technology monitoring of clomiphene citrate ovulation induction.  70:165-168. 1998

Measurement of total serum testosterone levels using commercially available kits: High degree of between-kit variability.  69:286-292. 1998

Effect of ovarian steroid production on adrenal steroidogenesis? [6] (multiple letters).  70:1187-1189. 1998

Role of the ovary in the adrenal androgen excess of hyperandrogenic women.  69:851-859. 1998

Peripheral progesterone (P) levels and endometrial response to various dosages of vaginally administered P in estrogen-primed women.  68:810-815. 1997

Expectant management versus elective curettage for the treatment of spontaneous abortion.  68:601-606. 1997

Detection of CAH heterozygotes [5] (multiple letters).  68:182-184. 1997

Detection of CAH heterozygotes..  68. 1997

Comparison of the ultrasonic scalpel to CO2 laser and electrosurgery in terms of tissue injury and adhesion formation in a rabbit model.  67:382-386. 1997

Identification of early pregnancy landmarks by transvaginal sonography: Analysis by logistic regression.  68:168-170. 1997

Instrument cleaning services: A patch or another hale in the bucket? [2] (multiple letters).  68:566-567. 1997

Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women.  67:569-572. 1997

There's a hole in my bucket: The cost of disposable instruments.  67:13-15. 1997

Luteal support with both estradiol and progesterone after clomiphene citrate stimulation for in vitro fertilization.  66:587-592. 1996

The effect of routine breast examination on serum prolactin levels.  65:869-870. 1996

Antisperm antibodies in infertile women: Subclass distribution of immunoglobulin (Ig) A antibodies and removal of IgA sperm-bound antibodies with a specific IgA1 protease.  63:63-70. 1995

delta 5-Androstene-3 beta,17 beta-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile..  62:321-326. 1994

Blunt trocar laparoscopy.  61:1177-1180. 1994

Inhibition of adhesion reformation in the rabbit model by meclofenamate: An inhibitor of both prostaglandin and leukotriene production.  62:1262-1265. 1994

The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: Therapeutic response.  61:570-572. 1994

Δ⁵-Androstene-3β,17β-diol in healthy eumenorrheic women: Relationship to body mass and hormonal profile.  62:321-326. 1994

Comparison of intracervical, intrauterine, and intratubal techniques for donor insemination.  59:339-342. 1993

Credentialing for endoscopic surgery [5].  60:381-382. 1993

For sperm - Is closer to the egg an advantage or liability? [1].  60:376-377. 1993

Kallmann's syndrome: Pregnancy achieved through gamete intrafallopian transfer.  60:737-739. 1993

Laparoscopic surgery for ectopic pregnancies: Technology assessment and public health implications.  59:487-498. 1993

Allergic reactions to penicillin during in vitro fertilization and intrauterine insemination.  58:847-849. 1992

Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology.  58:302-306. 1992

Motility longevity of sperm samples processed for intrauterine insemination.  58:436-438. 1992

Operative endoscopy: The pressing need for a structured training and credentialing process.  58:1100-1102. 1992

The effect of cocaine on sperm motility characteristics and bovine cervical mucus penetration.  57:178-182. 1992

11 beta-hydroxylase deficiency in hyperandrogenism..  55:733-741. 1991

Effect of estrogen/progestin administration on the ovarian response to gonadotropins: A randomized, prospective study.  55:642-643. 1991

Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women.  56:427-433. 1991

Magnetic resonance imaging of the adrenal gland in women with late-onset adrenal hyperplasia.  56:142-144. 1991

No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease.  56:1179-1182. 1991

The effects of three serotypes of Ureaplasma urealyticum on spermatozoal motility and penetration in vitro.  55:170-176. 1991

Detection of antigalactosyltransferase antibodies in plasma from patients with antisperm antibodies.  54:133-137. 1990

Hormonal treatment of functional ovarian cysts: A randomized, prospective study.  54:775-777. 1990

Late onset adrenal hyperplasia: Mutation at codon 282 of the functional 21-hydroxylase gene is not ubiquitous.  54:819-823. 1990

Performance anxiety during infertility treatment: Effect on semen quality.  53:337-340. 1990

Secretory immune system of the female reproductive tract. II. Local immune system in normal and infected fallopian tube.  54:51-55. 1990

Comparison between 1-hour and 24-hour follow-up radiographs in hysterosalpingography using oil based contrast media.  52:753-755. 1989

Postoperative recuperation: Relation to the extent of endoscopic surgery.  51:1061-1064. 1989

Reproductive endocrinologic alterations in female asymptomatic obesity.  52:703-725. 1989

Are we exploiting the infertile couple?.  48:735-739. 1987

Congenital adrenal hyperplasia: Long-term results following vaginal reconstruction.  46:1011-1014. 1986

Determination of antisperm antibodies in infertile couples by millititer filtration.  45:299-301. 1986

Long-term medical therapy and follow-up of pediatric-adolescent patients with prolactin-secreting macroadenomas.  45:713-716. 1986

Regulation of human prolactin secretion by gonadotropin-releasing hormone in vitro.  46:26-31. 1986

Report of the National Symposium on the Clinical Management of Prolactin-Related Reproductive Disorders..  45:607-610. 1986

Diagnosis and management of prolactinomas.  43:5-16. 1985

In vitro and in vivo evaluation of latex condoms using a two-phase nonoxynol 9 system.  43:931-936. 1985

Detection of ovulation.  41:680-681. 1984

Long-term monolayer culture of human anterior pituitary cells: Functional validation of a method.  41:75-80. 1984

Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: A multicenter study.  39:744-748. 1983

Evaluation of Delestrogen and Parlodel as a luteolytic agent in humans.  37:213-217. 1982

Patients with unexplained infertility..  38:261-262. 1982

An estrogen-bromocriptine regimen as a potential means of fertility regulation.  35:241. 1981

Inhibition of peritoneal adhesion re-formation after lysis with thirty-two per cent dextran 70..  35:592-593. 1981

Microsurgical reversal of female sterilization..  36:122-123. 1981

Assessment of pituitary function in patients with serum prolactin levels greater than 100 ng/ml.  32:177-182. 1979